TITLE

Oral factor Xa inhibitor YM150 effective for VTE prophylaxis in hip replacement

AUTHOR(S)
Muntz, James E.
PUB. DATE
March 2008
SOURCE
Hem/Onc Today;3/10/2008, Vol. 9 Issue 4, p29
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article discusses research on the effectiveness of oral factor Xa inhibitor YM150 in patients undergoing elective primary hip replacement. According to the study which involved 1,017 patients, YM150 was effective in venous thromboembolism prophylaxis. The Xa inhibitor was administered between six to ten hours after the hip replacement surgery.
ACCESSION #
31672196

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics